Microbiome Tests Guide: Shotgun Metagenomics vs PCR, 16S, and RNA-Seq

Illustration of microbes with the left side in sharp detail and the right side pixellated representing microbiome testing technology comparisons

Summary

Could gut health hold the key? Test, don't guess. Learn more
Could gut health hold the key? Test, don't guess. Learn more

The human microbiome is home to trillions of microbes—bacteria, fungi, parasites, viruses, and more—that play a major role in our health [1], [2]. As interest in the microbiome and its impact on overall wellness grows, so does the demand for stool and microbiome tests that help uncover what’s going on inside. 

But not all tests are created equal.

Depending on the type of technology used, a test might give you a broad overview of your microbiome, or it might zero in on one specific issue. In this article, we’ll explore the accuracy of common microbiome testing methods, explain how they work, and show why Tiny Health uses a powerful technology called shotgun metagenomics to give families the most comprehensive and accurate gut health insights.

What to expect from a comprehensive stool test

A comprehensive Tiny Health gut microbiome test with a phone and PDF of test results

A comprehensive stool test can tell you more than just which bacteria live in your gut. It can reveal your gut’s functional capacity (what it does and how well it functions), whether harmful microbes are present, and what steps you can take to support your health.

Here’s what a high-quality stool test may show:

  • Bacterial balance: The composition of your gut microbiome, and how well beneficial and potentially disruptive bacteria are balanced.
  • Presence of pathogens: Whether you have potentially disruptive microbes including certain bacteria, yeasts, or parasites, which may be impacting your gut health.
  • Gut health indicators: Revealing critical information about food digestion, immune support, inflammation potential, and production of short-chain fatty acids.
  • Markers for health conditions: Indicators of gut imbalances that may be associated with conditions such as inflammatory bowel disease (IBD), Small intestinal bacterial overgrowth (SIBO), or other gut-related conditions. Personalized recommendations: Based on your results, you may receive tailored advice for dietary changes, probiotics, or supplements to address imbalances and optimize your gut microbiome for improved digestion, immune response, and overall well-being. 
  • Expert Guidance: Some testing companies like Tiny Health offer access to trained professionals who help navigate results, address concerns, and prioritize next steps with strategies to enhance health.

Most gut microbiome tests focus on bacteria through DNA sequencing. But comprehensive stool tests can go deeper, helping you understand how your gut is functioning and what to do next. Both types of tests have unique benefits and can often be used together for a more complete picture of gut health.

Comparing microbiome testing technologies

Microbiome science has come a long way, from culturing bacteria in labs to sophisticated DNA and RNA sequencing tools. Let’s discuss the main testing methods and how they compare.

Table titled "Microbiome Testing Technology Advantages and Limitations" comparing shotgun metagenomics, PCR & qPCR, 16S rRNA, RNA, and culture-based testing methods.

Culture-based stool tests: the old-school method

This is the traditional diagnostic tool used by many laboratories around the world. In the culture-based method, microbiologists grow microbes from a stool sample on special plates to identify specific microbes and to test how they respond to antibiotics. 

Culture-based tests, however, are time-consuming with results taking 1-3 days [3]. They also have a low diagnostic yield—only about 1.5% lead to a clear diagnosis [4]. Because they only detect the specific microbes being tested, they may miss pathogens like Campylobacter and E. coli. Plus, they do not measure how many microbes are present in the sample.

PCR and qPCR: the diagnostic standard

Polymerase Chain Reaction (PCR) is a testing method that copies tiny pieces of DNA to detect specific microbes. Quantitative PCR (qPCR) is a more advanced form that uses fluorescent markers to measure how much of the microbe is present in real time [5]. These tests target specific genes, like those responsible for antibiotic resistance and the 16s rRNA gene found in all bacteria. 

These fast and highly accurate tests are especially useful in clinical settings for diagnosing conditions like diarrhea, stomach bugs, and even parasite infections. Major healthcare providers like LabCorp and Quest Diagnostics use qPCR for its precision and speed.

Despite their efficiency and cost-effectiveness for focused applications, PCR methods have limitations [6]. Their focus on specific microbes means they don't provide a complete picture of the microbiome. If you’re interested in assessing overall gut health and the balance of beneficial and disruptive microbes, comprehensive tests may be more appropriate. 

16S rRNA sequencing: a bird’s eye view of the microbial community 

This sequencing method looks at one gene shared by all bacteria—the 16S ribosomal RNA (rRNA) gene—to identify and quantify bacteria in a sample. This method compares sequenced genes with known databases, classifying microbes primarily at the genus or family level.

While 16S sequencing helps identify types of bacteria in the gut, it can’t tell the exact species or strains. Moreover, it doesn’t detect other microbes like fungi or viruses [7]. Its results can also be biased by the way the test is performed.

An illustration showing Tiny Health's deep shotgun metagenomic sequencing on the left with high resolution detail in microbes and functions, and 16s amplicon sequencing on the right with low resolution detail.
16S amplicon sequencing technology lacks the detail of shotgun metagenomic sequencing technology.

In research studies, 16S rRNA sequencing is a fast and economical way to survey a microbial community [7]. However, it cannot analyze metabolic functions or detailed interactions within the microbiome.

Shotgun metagenomics: Tiny Health’s choice

Shotgun metagenomics is regarded as the gold standard in microbiome analysis [8]. This high-resolution technology is central to Tiny Health's approach to gut health. It sequences all of the microbial DNA in your sample, not just a few genes. This means we can identify every microbe—even rare ones—down to the species and strain level [9], [10]. 

An illustration titled, "Microbes we can see" showing beneficial bacteria, pathogens, parasites, and fungi
Using shotgun metagenomics, Tiny Health tests can identify over 120,000 microbes in high detail, down to the strain level.

Because it’s based on DNA, shotgun metagenomics provides stable and consistent results, which are crucial for tracking changes in the gut microbiome over time. This stability is a significant advantage over RNA sequencing, which can vary greatly from test to test.

Beyond its reputation as a detailed and reliable testing method, shotgun sequencing can also give us deep insights into gut microbiome function [10]. In other words, we can understand what your microbes are capable of doing for digestion, immune system interactions, and overall health. 

When you see the words shotgun metagenomics, think comprehensive. It gives the most thorough picture of your microbiome’s composition and capabilities. This is why it is the gold standard for groundbreaking scientific research. Because of its high-definition detail,  these tests support personalized interventions based on functional insights, leading to better health outcomes for you.

RNA sequencing: dynamic but variable

RNA sequencing (RNA-Seq) is a method that shows which genes are active in a cell at a specific moment, like taking a snapshot of gene activity. This technology is great for clinical research and observing how the gut microbiome responds to environmental changes or treatments in short periods of time [11].

Despite these benefits, RNA-Seq has limitations, especially in consumer tests. RNA  degrades quickly [12]. This instability leads to variable results. This inconsistency is a problem if you’re tracking your gut health over time. RNA-Seq is more expensive than DNA-based methods and is prone to multiple sources of experimental bias—including during RNA extraction, reverse transcription, adapter ligation, and PCR amplification—which can distort results and complicate interpretation [13].

No extensive studies using RNA-Seq for dietary or supplemental interventions have been published, so its effectiveness for consumer health products is unproven. While RNA-Seq offers invaluable insights for specific clinical research scenarios, its challenges and costs make it a less ideal option. 

Why Choose Tiny Health?

At Tiny Health, we believe families deserve clear answers, not guesswork. That’s why we use shotgun metagenomics, the most advanced DNA sequencing technology available today. It delivers deep, accurate, and actionable insights you simply won’t get from older microbiome testing methods.

Our tests don’t just list which microbes are present. We show you how your entire microbiome is working—how balanced it is, whether it’s fueling or fighting inflammation, and what changes might make the biggest difference. With personalized, science-backed recommendations, you can track your progress over time and take control of your health journey. 

Whether you're a health practitioner, parent, or wellness enthusiast, we give you the tools to make confident, informed decisions for a healthier future. Explore our full suite of gut and vaginal health tests and unlock the power of the microbiome. 

A Tiny Health Gut Health Test showing a gut health report on a phone app and printed PDF report

Trust your gut.

Get to know your microbes with an easy, 5-minute at-home test from Tiny Health. Unlock deep gut health insights and personalized recommendations for your diet, supplements, and lifestyle.

References

  1. K. Hou et al., “Microbiota in health and diseases,” Signal Transduct Target Ther, vol. 7, no. 1, p. 135, Apr. 2022, doi: 10.1038/s41392-022-00974-4.
  2. A. Sarkar et al., “The association between early-life gut Microbiota and long-term health and diseases,” J. Clin. Med., vol. 10, no. 3, p. 459, Jan. 2021, doi: 10.3390/jcm10030459.
  3. J. M. Miller et al., “A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the infectious diseases society of America and the American society for microbiology,” Clin. Infect. Dis., vol. 67, no. 6, pp. e1–e94, Aug. 2018, doi: 10.1093/cid/ciy381.
  4. J. Y. Lee et al., “Diagnostic yield of stool culture and predictive factors for positive culture in patients with diarrheal illness,” Medicine (Baltimore), vol. 96, no. 30, p. e7641, Jul. 2017, doi: 10.1097/MD.0000000000007641.
  5. P. Kralik and M. Ricchi, “A Basic Guide to Real Time PCR in Microbial Diagnostics: Definitions, Parameters, and Everything,” Front. Microbiol., vol. 8, p. 108, Feb. 2017, doi: 10.3389/fmicb.2017.00108.
  6. C. J. Smith and A. M. Osborn, “Advantages and limitations of quantitative PCR (Q-PCR)-based approaches in microbial ecology,” FEMS Microbiol. Ecol., vol. 67, no. 1, pp. 6–20, Jan. 2009, doi: 10.1111/j.1574-6941.2008.00629.x.
  7. D. L. Church et al., “Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory,” Clin. Microbiol. Rev., vol. 33, no. 4, pp. e00053-19, Sep. 2020, doi: 10.1128/cmr.00053-19.
  8. B. Hillmann et al., “Evaluating the Information Content of Shallow Shotgun Metagenomics,” mSystems, vol. 3, no. 6, Nov. 2018, doi: 10.1128/msystems.00069-18.
  9. X. Zhang et al., “Advancing functional and translational microbiome research using meta-omics approaches,” Microbiome, vol. 7, no. 1, p. 154, Dec. 2019, doi: 10.1186/s40168-019-0767-6.
  10. C. Quince et al., “Shotgun metagenomics, from sampling to analysis,” Nat. Biotechnol., vol. 35, no. 9, pp. 833–844, Sep. 2017, doi: 10.1038/nbt.3935.
  11. S. Bashiardes et al., “Use of Metatranscriptomics in Microbiome Research,” Bioinform. Biol. Insights, vol. 10, pp. 19–25, Apr. 2016, doi: 10.4137/BBI.S34610.
  12. J. Richards et al., “Quality control of bacterial mRNA decoding and decay,” Biochim. Biophys. Acta, vol. 1779, no. 9, pp. 574–582, Sep. 2008, doi: 10.1016/j.bbagrm.2008.02.008.
  13. H. Shi et al.,“Bias in RNA-seq library preparation: Current challenges and solutions,” Biomed Res. Int., vol. 2021, p. 6647597, Apr. 2021, doi: 10.1155/2021/6647597.